-transparent.png){kind=logo}
Out of 79 patients with metastasized carcinoma of the breast in 33% (6 patients) a response to a Tamoxifen therapy could be observed. For complete remissions the remission periods were 12.3 months, for partial remissions 9.9 months and in the group of constant findings 4.9 months. Preferably metastases of the soft parts respond to the therapy. The side effects are very insignificant. The indications for the tamoxifen therapy are represented as well as the importance of the determination of hormone receptors.
Related Publications
A Köhler, and
W Noss, and
N Dobberstein, and
R Stoltmann, and
J Pohl
October 1978,
L'union medicale du Canada,
A Köhler, and
W Noss, and
N Dobberstein, and
R Stoltmann, and
J Pohl
December 1985,
Wiener medizinische Wochenschrift (1946),
A Köhler, and
W Noss, and
N Dobberstein, and
R Stoltmann, and
J Pohl
November 1996,
Therapeutische Umschau. Revue therapeutique,
A Köhler, and
W Noss, and
N Dobberstein, and
R Stoltmann, and
J Pohl
September 1969,
Schweizerische medizinische Wochenschrift,
A Köhler, and
W Noss, and
N Dobberstein, and
R Stoltmann, and
J Pohl
July 1979,
Ugeskrift for laeger,
A Köhler, and
W Noss, and
N Dobberstein, and
R Stoltmann, and
J Pohl
October 1971,
Zeitschrift fur Allgemeinmedizin,
A Köhler, and
W Noss, and
N Dobberstein, and
R Stoltmann, and
J Pohl
February 2005,
Bulletin du cancer,
A Köhler, and
W Noss, and
N Dobberstein, and
R Stoltmann, and
J Pohl
December 1977,
Deutsche medizinische Wochenschrift (1946),
A Köhler, and
W Noss, and
N Dobberstein, and
R Stoltmann, and
J Pohl
May 1978,
Die Medizinische Welt,
A Köhler, and
W Noss, and
N Dobberstein, and
R Stoltmann, and
J Pohl
January 1978,
La Clinica terapeutica,
